New chemo drug may help treat prostate cancerMay 31st, 2008 - 1:33 pm ICT by admin
Washington, May 31 (ANI): Researchers from Oregon Health and Science University have found a new chemotherapy drug that may help treat prostate cancer.
The new study showed that men with a certain type of prostate cancer responded well to new drug, Sagopilone, plus prednisone.
To analyse the effectiveness of the drug, the researchers conducted the study on men with androgen-independent prostate cancer with the most advanced form of prostate cancer.
Their cancer had metastasized, which means it had spread beyond the prostate and was no longer responding to hormonal therapies.
“We are showing solid activity that this drug shows promise,” said Dr Tomasz Beer, principal investigator, Grover C. Bagby Endowed Chair for Cancer Research, director of the Prostate Cancer Research Program at the OHSU Cancer Institute and associate professor of medicine (hematology/medical oncology), OHSU School of Medicine.
The participants were given Sagopilone and prednisone. A majority showed positive results in the reduction of their prostate specific antigens, or PSA, which is often elevated in the presence of prostate cancer.
The findings revealed that thirteen study participants had a more than 50 percent reduction in their PSA. Another 23 showed a 30 percent reduction and one who had radiographic measurable disease showed complete response
Four had unconfirmed prostate response. A 30 percent reduction in PSA levels in three months is a strong indicator of survival.
“We look forward to completing this study and to the further investigation of Sagopilone as a new treatment option for men with advanced prostate cancer,” said Beer.
Sagopilone, a fully synthetic derivation, is a new class of drug that inhibits growth and the spread of malignant cell, similar to docetaxel, which has been the gold standard for this type of hormone independent prostate cancer.
This research was presented at the annual American Association of Clinical Oncology in Chicago. (ANI)
- New method detects aggressive prostate cancer - Aug 09, 2012
- FDA Authorizes A New Prostate Cancer Drug - Jun 18, 2010
- Potent anticancer drug isolated from weed - Jul 10, 2012
- Genetic markers could help detect early prostate cancer onset - Jun 08, 2010
- Chemo-radiation combo may avert prostate cancer recurrence - Nov 05, 2009
- New test accurately detects aggressive prostate cancer - Apr 07, 2011
- PSA test more reliable in men taking prostate-shrinking drug - Dec 18, 2010
- Change in PSA level poor predictor of prostate cancer - Feb 25, 2011
- MRI can help locate prostate cancer recurrence at extremely low PSA levels - Apr 30, 2011
- Losing hair at 20 linked to increased risk of prostate cancer - Feb 16, 2011
- Beer may prevent prostate cancer - Dec 09, 2009
- Experimental drug for advanced prostate cancer shows promise - Apr 15, 2010
- Molecule discovery good news for prostate cancer sufferers - Dec 29, 2009
- FDA approves prostate cancer drug Jevtana - Jun 18, 2010
- Combo therapy for enlarged prostate more effective - Mar 03, 2010
Tags: cancer institute, cancer research program, chemo drug, chemotherapy drug, clinical oncology, docetaxel, hormonal therapies, malignant cell, measurable disease, metastasized, ohsu, oregon health, prednisone, prostate cancer, prostate cancer research, prostate specific antigens, psa levels, science university, study participants, treatment option